Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/07/2012CN101528710B Aminomethyl-4-imidazoles
11/07/2012CN101528707B 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
11/07/2012CN101524399B Compound and preparation method and application thereof
11/07/2012CN101519345B Trans-3,5-dihydroxyl-4'-bromo butoxyl toluylene as well as preparation and application thereof
11/07/2012CN101518521B New medical application of cedrol
11/07/2012CN101497603B Benzimidazole derivative containing alkoxy alkanamine oxyl substituted pyridine
11/07/2012CN101491668B Composition with blood-sugar reducing function and preparation method thereof
11/07/2012CN101448802B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment
11/07/2012CN101415422B Anti-cancer pharmaceutical composition
11/07/2012CN101402583B Levorotation carnitine acid calcium phosphate, preparation method and use thereof
11/07/2012CN101380313B Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof
11/07/2012CN101356971B Anti-fatigue anti-hypoxia health food composition
11/07/2012CN101353664B siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof
11/07/2012CN101312656B Food supplement
11/07/2012CN101284881B Coarse powder of glucomannan
11/07/2012CN101268047B Crystalline and amorphous sodium atorvastatin
11/07/2012CN101264121B Blood fat reducing health products and preparation
11/07/2012CN101247736B Compositions and methods for improving integrity of functional blood vessel, cellular survival and decreasing Programmed cell death in ischemia or after ischemia in the brain
11/07/2012CN101242839B Azaindazole compounds and methods of use
11/07/2012CN101234117B Medical use of a pair of ginseng saponin aglycones and their mixture
11/07/2012CN101217946B Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use
11/07/2012CN101203245B Injection formula for RNA
11/07/2012CN101198309B Use of hair protection composition in preparing hair protection agent
11/07/2012CN101193561B Dietary fiber composition comprising glucomannan, xanthan gum, and alginate
11/07/2012CN101171009B Use of non-imidazole alkylamines histamine h3- receptor ligands in treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/07/2012CN101155781B Pyridine-3-carboxamide derivatives as cb1 inverse agonists
11/07/2012CN101132693B Compositions and methods for the management of hyperproliferative dermatological conditions
11/07/2012CN101120926B Freezing-dried preparation containing voriconazole and its preparation method
11/07/2012CN101117328B Fatty acid synthetase inhibitor and application for treating bacterial infection
11/07/2012CN101074223B Versulin derivative and its use in treatment of diabetes and its complication
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
11/07/2012CN101062024B Pronin medicinal composition and its preparing method
11/07/2012CN101057834B Solid preparation comprising enteric solid dispersion
11/07/2012CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
11/07/2012CN101001837B Indole derivatives comprising an acetylene group as PPAR activators
11/06/2012USRE43797 Methods of administering tetrahydrobiopterin
11/06/2012US8304557 Fused heterocycle derivatives and use thereof
11/06/2012US8304556 Thiazolyl-dihydro-indazoles
11/06/2012US8304552 Fatty acid niacin conjugates and their uses
11/06/2012US8304551 Fatty acid niacin conjugates and their uses
11/06/2012US8304547 Azolecarboxamide compound or salt thereof
11/06/2012US8304455 Compositions and methods of their use for improving the condition and appearance of skin
11/06/2012US8304454 Antimicrobial cellulose sponge and method of making
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304451 Histone deacetylase and tubulin deacetylase inhibitors
11/06/2012US8304450 Stable pharmaceutical compositions with docetaxel
11/06/2012US8304449 Inhibitors of cyclin dependent kinases and their use
11/06/2012US8304448 Method for the treatment of metabolic disorder containing benzazole derivatives as an active ingredient
11/06/2012US8304447 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
11/06/2012US8304446 Compounds
11/06/2012US8304445 7-pyrazolyl tetracycline compounds and methods of use thereof
11/06/2012US8304443 Indazole derivatives
11/06/2012US8304442 Compounds having immunomodulator activity
11/06/2012US8304441 Thiazolidinedione analogues for the treatment of metabolic diseases
11/06/2012US8304440 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
11/06/2012US8304439 Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage
11/06/2012US8304438 Heteroarylacrylamides and their use as pharmaceuticals
11/06/2012US8304437 Carboxamide compound and use of the same
11/06/2012US8304436 Pyrazolone derivatives as PDE4 inhibitors
11/06/2012US8304435 Deuterium-enriched donepezil
11/06/2012US8304434 Substituted aryl sulfone derivatives as calcium channel blockers
11/06/2012US8304433 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
11/06/2012US8304432 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
11/06/2012US8304431 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
11/06/2012US8304430 Phosphonic acid compounds as inhibitors of serine proteases
11/06/2012US8304429 Methods for preventing and/or treating degenerative disorders of the central nervous system
11/06/2012US8304428 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
11/06/2012US8304427 Acylthiourea compound or salt thereof, and use thereof
11/06/2012US8304426 Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it
11/06/2012US8304425 Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
11/06/2012US8304424 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
11/06/2012US8304423 Modulators of muscarinic receptors
11/06/2012US8304421 Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
11/06/2012US8304420 Substituted quinazolines for reducing platelet count
11/06/2012US8304419 Chemical compounds
11/06/2012US8304418 Pyrazolopyrimidinone kinase inhibitor
11/06/2012US8304417 Crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/06/2012US8304416 Chromenone derivatives
11/06/2012US8304415 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304413 Compounds and methods for treating inflammatory and fibrotic disorders
11/06/2012US8304412 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
11/06/2012US8304411 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/06/2012US8304410 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8304408 Wnt signaling inhibitors, and methods for making and using them
11/06/2012US8304407 8-substituted benzoazepines as toll-like receptor modulators
11/06/2012US8304406 Compounds for treating pulmonary hypertension
11/06/2012US8304405 Combination of azelastine and ciclesonide for nasal administration
11/06/2012US8304404 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
11/06/2012US8304403 Heterocyclic CETP inhibitors
11/06/2012US8304402 Composition and method for treating nosebleeds
11/06/2012US8304401 Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels
11/06/2012US8304400 Compositions and methods for inhibiting tumor growth and metastasis
11/06/2012US8304399 Hedgehog signaling pathway proteins and uses thereof
11/06/2012US8304398 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
11/06/2012US8304396 Immunostimulatory nucleic acids
11/06/2012US8304395 Lipid conjugates in the treatment of disease
11/06/2012US8304394 Low side effect pharmaceutical composition containing isoniazid